ROME Therapeutics Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
ROME Therapeutics is a biotechnology research company pursuing novel therapies for cancer and autoimmune diseases by investigating the repeatome, portions of the genome that have historically been described as junk DNA. The company was launched in April 2020 and incubated at GV, in collaboration with ARCH Venture Partners and Partners Innovation Fund. Based in Boston, Massachusetts, it employs between 11 and 50 people. Its research teams span oncology, immunology, virology and machine learning, and the company has identified several drug targets and multiple discovery programs. The company reports annual revenue in the range of $1 million to $10 million.